Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic... Show more
The Moving Average Convergence Divergence (MACD) for EDTXF turned positive on October 17, 2025. Looking at past instances where EDTXF's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EDTXF's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on October 16, 2025. You may want to consider a long position or call options on EDTXF as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
EDTXF moved above its 50-day moving average on October 14, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDTXF advanced for three days, in of 157 cases, the price rose further within the following month. The odds of a continued upward trend are .
EDTXF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDTXF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for EDTXF entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EDTXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.122). P/E Ratio (0.000) is within average values for comparable stocks, (140.368). EDTXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.782). EDTXF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). EDTXF's P/S Ratio (172.414) is very high in comparison to the industry average of (9.606).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TIEWX | 16.94 | 0.08 | +0.47% |
Nuveen International Eq W | |||
SCSIX | 42.34 | 0.10 | +0.24% |
Sterling Capital SmCp Val R6 | |||
AGTIX | 171.49 | 0.04 | +0.02% |
AB Sustainable Global Thematic I | |||
MSCYX | 14.84 | -0.03 | -0.20% |
MassMutual Small Cap Gr Eq Svc | |||
PAHSX | 7.06 | -0.03 | -0.42% |
PGIM Jennison NextGeneration Glb Opps A |
A.I.dvisor tells us that EDTXF and ASAPF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and ASAPF's prices will move in lockstep.
Ticker / NAME | Correlation To EDTXF | 1D Price Change % | ||
---|---|---|---|---|
EDTXF | 100% | -2.14% | ||
ASAPF - EDTXF | 22% Poorly correlated | N/A | ||
KSRBF - EDTXF | 21% Poorly correlated | N/A | ||
TDSGF - EDTXF | 20% Poorly correlated | N/A | ||
FSPKF - EDTXF | 3% Poorly correlated | N/A | ||
DSRLF - EDTXF | 3% Poorly correlated | N/A | ||
More |